Bovicure Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 31-12-2024
- Paid Up Capital ₹ 0.60 M
as on 31-12-2024
- Company Age 11 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 12.09 Cr
as on 31-12-2024
- Revenue 112.10%
(FY 2022)
- Profit -3.84%
(FY 2022)
- Ebitda 70.61%
(FY 2022)
- Net Worth 26.12%
(FY 2022)
- Total Assets 41.31%
(FY 2022)
About Bovicure Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹12.09 Cr.
Ram Saxena and Sushila serve as directors at the Company.
- CIN/LLPIN
U74900HR2013PTC050746
- Company No.
050746
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Oct 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Hisar, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Bovicure Pharma Private Limited offer?
Bovicure Pharma Private Limited offers a wide range of products and services, including Animal Medicines & Health Care, Veterinary Injections, Hand Sanitizers & Personal Hygiene, Beauty Soap, Insecticides and Pesticides, Acaricide, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Bird Food, Poultry & Animal Food, Animal Feed Supplement.
Who are the key members and board of directors at Bovicure Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ram Saxena  | Director | 19-Nov-2015 | Current |
| Sushila | Director | 01-Aug-2016 | Current |
Financial Performance of Bovicure Pharma.
Bovicure Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 112.1% increase. The company also saw a slight decrease in profitability, with a 3.84% decrease in profit. The company's net worth Soared by an impressive increase of 26.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bovicure Pharma?
In 2022, Bovicure Pharma had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹120.90 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 7.10 Cr
- Yes Bank Limited : 3.29 Cr
- Axis Bank Limited : 1.50 Cr
- Hdfc Bank Limited : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Oct 2024 | Canara Bank | ₹7.10 Cr | Open |
| 09 Feb 2024 | Yes Bank Limited | ₹3.29 Cr | Open |
| 13 Nov 2022 | Axis Bank Limited | ₹1.50 Cr | Open |
| 30 Jan 2018 | Hdfc Bank Limited | ₹2.00 M | Open |
How Many Employees Work at Bovicure Pharma?
Bovicure Pharma has a workforce of 16 employees as of Mar 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bovicure Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bovicure Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
